Exclusive - Will Address USFDA Letters In May: Lupin
  • WebDesk BTVI
  • Feb 26 2018

February 26: Speaking On The Sidelines Of Indian Pharmaceutical Forum 2018, Nilesh Gupta, Managing Director At Lupin Said That The Company Would Soon Address The Warning Letters On Goa And Indore Plants, Gave His Outlook On US Generics Market And Also Shared His Perspective On Lupin's Complex Generics Pipeline.